Cancer News and Research

Latest Cancer News and Research

VentiRx presents VTX-2337 Phase 1 trial results against advanced solid tumors at ASCO 2011

VentiRx presents VTX-2337 Phase 1 trial results against advanced solid tumors at ASCO 2011

Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC

Exelixis reports encouraging interim data from cabozantinib phase 2 trial for metastatic CRPC

ImaginAb, Oxford BioMedicaplc enter research deal to develop in vivo diagnostic imaging agent

ImaginAb, Oxford BioMedicaplc enter research deal to develop in vivo diagnostic imaging agent

Tragara's apricoxib-erlotinib Phase 2 study data on non-small cell lung cancer presented at ASCO 2011

Tragara's apricoxib-erlotinib Phase 2 study data on non-small cell lung cancer presented at ASCO 2011

Female cancer survivors benefit from natural nutritional supplement

Female cancer survivors benefit from natural nutritional supplement

Tai Chi may help overcome cognitive decline in patients receiving chemotherapy

Tai Chi may help overcome cognitive decline in patients receiving chemotherapy

Symphogen's Sym004 Phase 1 trial data on advanced solid tumors presented at ASCO 2011

Symphogen's Sym004 Phase 1 trial data on advanced solid tumors presented at ASCO 2011

Teva's lipegfilgrastim-pegfilgrastim comparative Phase III study in breast cancer meets primary endpoint

Teva's lipegfilgrastim-pegfilgrastim comparative Phase III study in breast cancer meets primary endpoint

Researchers reveal surprising link between cell's skeleton and organ size

Researchers reveal surprising link between cell's skeleton and organ size

Manhattan acquires Senior Scientific

Manhattan acquires Senior Scientific

Flaxseed of no use in menopausal hot flashes: Study

Flaxseed of no use in menopausal hot flashes: Study

Positive results from RXi NeuVax Phase 2 trial on breast cancer presented at ASCO 2011

Positive results from RXi NeuVax Phase 2 trial on breast cancer presented at ASCO 2011

Tikcro reports net loss of $30,000 for first quarter 2011

Tikcro reports net loss of $30,000 for first quarter 2011

Positive results from Celator CPX-351 Phase 2b study on acute myeloid leukemia presented at ASCO

Positive results from Celator CPX-351 Phase 2b study on acute myeloid leukemia presented at ASCO

Frog skin proteins could treat cancer, diabetes and stroke: New discovery

Frog skin proteins could treat cancer, diabetes and stroke: New discovery

DiagnoCure reports net loss of $1,601,439 for second quarter 2011

DiagnoCure reports net loss of $1,601,439 for second quarter 2011

AstraZeneca receives AmeriCares' Power of Partnership Award for global health programs

AstraZeneca receives AmeriCares' Power of Partnership Award for global health programs

PREMIER Biosoft, Waters partner to advance lipidomics research

PREMIER Biosoft, Waters partner to advance lipidomics research

Trifunctional antibody Catumaxomab triggers vaccination effect against cancer

Trifunctional antibody Catumaxomab triggers vaccination effect against cancer

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.